Background: Coronary heart disease (CHD) is a leading cause of death globally. Although
therapy with statins decreases circulating levels of low-density lipoprotein cholesterol and …

Relatively low numbers of kringle 4 type 2 repeats in apolipoprotein (a) and specific
haplotypes of the SLC22A3‐LPAL2‐LPA region on chromosome 6 are associated with an …

Background: Genetic studies have shown lipoprotein (a)(Lp [a]) to be an important causal
risk factor for coronary disease. Apolipoprotein (a) isoform size is the chief determinant of Lp …

Abstract Background/Aims: Lp (a) levels have long been recognized as a potential risk factor
for coronary heart disease that is almost completely under genetic control. Much of the …

Lipoprotein (a)[Lp (a)] is a highly atherogenic lipoprotein particle that may be found in high
concentrations in the blood of individuals who inherited Lp (a)-raising genetic variants. 1 …

Abstract Purpose of Review Lipoprotein (a)[Lp (a)] is a highly atherogenic lipoprotein
species. A unique feature of Lp (a) is the strong genetic determination of its concentration …

Background Elevated lipoprotein (a)[Lp (a)] level is an independent genetic risk factor that
increases the risk of atherosclerotic cardiovascular disease (ASCVD) by 2–4 fold. We aimed …

Introduction High blood levels of lipoprotein (a)[Lp (a)] were suggested to increase the risk of
preeclampsia. Because excessive coagulation is involved in preeclampsia and Lp (a) is a …

Abstract Lipoprotein (a)(Lp (a)) represents a quantitative trait in human plasma associated
with atherothrombotic disease. Large variation in the distribution of Lp (a) concentrations …

(Arterioscler Thromb Vasc Biol. 2012; 32: 1550–1551.) angiographically, but carotid stenosis
(≥ 50%) was assessed by Doppler ultrasound, and peripheral vascular disease by …